Loading
Latest filing published 18 Aug 2026 for Bluejay Diagnostics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Indranil Dey discloses dealings in Bluejay Diagnostics, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 1 February 2023 to 17 August 2026.
Purchases make up the whole of the open-market record (2 purchases, €4,771). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
Most recently, on 18 August 2026, the filings show a share grant in Bluejay Diagnostics, Inc. The clock since the last published purchase (14 December 2023) now reads 1,039 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations